Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become a
global pandemic. In addition to the acute pulmonary symptoms of coronavirus disease …

Background Recent reports on outbreak of SARS-CoV-2 coronavirus (COVID-19) have
shown its association with abnormal blood clots. The viral infection initiates inflammatory …

Abstract Coronavirus disease 2019 (COVID-19) is a prominent pandemic disease that
emerged in China and hurriedly stretched worldwide. There are many reports on COVID-19 …

Thromboembolic events are frequently reported in patients infected with the SARS-CoV-2
virus. The exact mechanisms of COVID-19-associated hypercoagulopathy, however, remain …

Introduction Characteristics of blood coagulation and its relation to clinical outcomes in
COVID‐19 patients are still rarely reported. We aimed to investigate the blood coagulation …

The novel Corona virus infection (Covid-19) first identified in China in December 2019 has
rapidly progressed in pandemic leading to significant mortality and unprecedented …

COVID-19 progression often involves severe lung injury, inflammation, coagulopathy, and
leukocyte infiltration into pulmonary tissues. The pathogenesis of these complications is …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread all over the world
immediately after the first patient infected with this virus was discovered in Wuhan, China, in …

Abstract In coronavirus disease 2019 (COVID-19), multiple thromboinflammatory events
contribute to the pathophysiology, including coagulation system activation, suppressed …

Since the onset of the global pandemic in early 2020, coronavirus disease 2019 (COVID-19)
has posed a multitude of challenges to health care systems worldwide. In order to combat …